Orrick advised ORIX Corporation USA on the deal. ORIX Corporation USA (ORIX USA), the U.S. subsidiary of ORIX Corporation, a publicly-owned Tokyo-based international financial services company, […]
ORIX Corporation USA’s Equity Investment in Three Renewable Natural Gas Projects
VEF’s Uplisting on Nasdaq Stockholm’s Main Market
Orrick and Vinge advised VEF on the deal. VEF announced its listing change from Nasdaq First North Growth Market to Nasdaq Stockholm’s Main Market, which was approved […]
Convergenta’s Investment in CECONOMY
Orrick advised Convergenta Invest GmbH on the deal. Convergenta Invest GmbH, an investment company of the Media-Markt founding family Kellerhals, announced the acquisition of shares in CECOMOMY […]
Let’s Do This’ $60 Million Series B Financing Round
Orrick advised Let’s Do This on the deal. Let’s Do This, an endurance events marketplace, announced its $60 million Series B round led by Craft Ventures […]
EcoVadis’ $500 Million Fundraising
Jones Day advised EcoVadis on the deal. Orrick advised Princeville Capital. Goodwin Procter represented Astorg. EcoVadis, a leading global sustainability rating firm, announced its $500 million fundraising. […]
Aledade’s $123 Million Series E Financing Round
Orrick advised Aledade on the deal. Aledade announced its $123 million Series E financing round. Returning investor OMERS Growth Equity led the round, which also included Fidelity […]
Assembled’s $51 Million Series B Financing Round
Orrick advised Assembled on the deal. Assembled announced its $51 million Series B financing round. Led by New Enterprise Associates, the round included existing investors Emergence Capital […]
Catalyst Biosciences’ $60 Million Sale of Complement Portfolio
Orrick advised Catalyst Biosciences, Inc. on the deal. South San Francisco-based biopharmaceutical company Catalyst Biosciences, Inc. (NASDAQ: CBIO) announced the sale of its complement asset portfolio for […]
Fisker’s Launch of $350 Million At-the-Market Equity Program
Orrick advised Fisker on the deal. Fisker (NYSE: FSR) announced the establishment of its at-the-market equity program with J.P. Morgan Securities and Cowen and Company as […]
OKYO Pharma’s U.S. Initial Public Offering
Orrick advised OKYO Pharma on the deal. OKYO Pharma Limited (Nasdaq: OKYO; LSE: OKYO), a biotechnology company focused on the discovery and development of novel molecules […]
CBRE’s $100 Million Investment in Industrious
Orrick advised Industrious on the deal. Industrious announced its $100 million convertible preferred-equity investment by CBRE Group (NYSE: CBRE), the world’s largest commercial real estate services […]
XGIMI’s Acquisition of Baidu’s Aladdin Business
Orrick advised Baidu on the deal. Baidu, Inc. (Nasdaq: BIDU), the leading Chinese language Internet search provider and one of the largest AI and Internet companies […]